Multiple sclerosis Nervous System Diseases Multiple sclerosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: 1. Patients with relapsing remitting MS 2. Currently use a first line drug 3. Not previously been exposed to the decision to begin with a second line drug 4. Aged 18 years and over Doctors: 1. All doctors working in the Neurological department of Akershus University Hospital 2. Regularly meet multiple sclerosis patients
Exclusion criteria
Exclusion criteria: No exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of information provided by the doctors that is recalled by the patients is measured using patient interviews immediately after the consultation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Patient involvement is measured using: 1.1. Control preference scale (Degner et al), before and after consultation (patients and doctors) 1.2. MAPPIN’ SDM (Kasper et al.) after the consultation (patients and doctors) 1.3. Collaborate (Elwyn et al.) after the consultation (patients only) 2. Communication and information quality is measured using the Four Habits Patient Questionnaire (patients) 3. Doctor communication self-efficacy is measured using Parle et al.’s self-efficacy questionnaire before and after the consultation and three months later 4. Adherence to information principles is measured through reviewing the video recordings of the sessions using the Four Habits Coding Scheme | — |
Countries
Norway